Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Chugai Files for Additional Indication for Hemlibra in Japan
November 12, 2021
- Nippon Shinyaku Inks Option Pact for Dynacure’s Antisense in Japan
November 11, 2021
- Pfizer’s COVID-19 Vaccine Filed for Children 5 to 11 in Japan
November 10, 2021
- Otsuka, Takara Bio to Call Off Collaboration for Two Drug Candidates
November 10, 2021
- MSD Launches Antibiotic Recarbrio in Japan
November 10, 2021
- 6 Wholesalers Raided over Suspected Bid-Rigging in Kyushu
November 10, 2021
- Japan Ethical Drug Sales Rise 4.0% in September: Crecon
November 9, 2021
- Lilly, Torii to Wind Up Taltz Marketing Collaboration in Japan
November 9, 2021
- Ono’s BTK Inhibitor Velexbru Approved in South Korea
November 9, 2021
- Takecab Top-Seller Medicine in Japan in October: Encise
November 8, 2021
- AnGes COVID-19 Vaccine Falls Short in Clinical Trials, Focus Now on High Doses
November 8, 2021
- New EA Pharma CEO Eager to Put Company Back on Growth Track by Boosting Its Sales Strength
November 5, 2021
- Nippon Shinyaku Establishes Local Subsidiary in Beijing
November 5, 2021
- Ferring, Fuji Pharma Tie Up for Cervical Ripening Agent Propess
November 5, 2021
- Enhertu Application Accepted in Europe for 2nd Line Gastric Cancer: Daiichi Sankyo/AZ
November 5, 2021
- Plunge in COVID-19 Cases Stalling Japan Avigan Study by Few Months
November 5, 2021
- Otsuka’s In-Vitro Diagnostic for ALL Now under Health Coverage
November 4, 2021
- Axcelead Inks Research Pact with Kyowa Kirin, xFOREST on Drugs Targeting RNA Structures
November 4, 2021
- Fuji Pharma Files Contraceptive in Thailand
November 4, 2021
- Mitsubishi Tanabe Sales Rise 1.9% in 1st Half on Stelara Growth at Home
November 4, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…